Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1551–1600 of 75328
Cathleen DeGenova, who is retiring, will continue to serve as Senior Vice President and Chief Accounting Officer until June 14, 2026.
On May 22, 2026, Megan Boston, the Company’s chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company’s ongoing Board composition and governance review.
On May 22, 2026, the Board of Directors (the “Board”) of Benitec Biopharma Inc. (the “Company”) appointed David Friedman to serve as a director of the Board, effective as of such date.
On May 26, 2026, Marc Nash informed Outset Medical, Inc. (the “Company”) of his decision to depart from the Company and his role as Executive Vice President, R&D, Operations and Service, effective June 5, 2026, to pursue other professional opportunities.
On May 25, 2026, the Board of Directors (the “Board”) of LENSAR, Inc. (the “Company”) appointed Michael A. Rossi to serve as the Company’s Interim Chief Financial Officer and principal financial officer, effective as of May 29, 2026.
On May 25, 2026, Anne O’Riordan, a Class III director whose term expires at the Jazz Pharmaceuticals plc (the “Company”) 2026 annual meeting of shareholders, has informed the board of directors (the “Board”) that she will not stand for re-election.
On May 26, 2026, Jonathan Frohlinger notified the Board of Directors of Morgan Stanley Direct Lending Fund (the “Company”) of his resignation as the Company’s Principal Accounting Officer, effective as of May 26, 2026.
On May 29, 2026, Celia Pelaz, the Chief Operating Officer of Spire Global, Inc. (the “Company”), informed the Company of her decision to resign from the Company to pursue a new role with another organization effective September 30, 2026.
Mr. Tucker resigned from the Board of Directors of the Company effective May 27, 2026.
On May 27, 2026, R. Hewitt Pate notified the Board of Directors of Chevron Corporation (“Chevron”) of his decision to resign as Chief Legal Officer of Chevron, effective December 31, 2026, in connection with his expected retirement in June 2027.
On May 26, 2026, Brent C. Jewell tendered his resignation as President of the Architectural Glass Segment of Apogee Enterprises, Inc. (the “Company”).
On May 28, 2026, UMH Properties, Inc. (the “Company”) announced that effective June 1, 2026, Anna T. Chew will retire from the role of the Company’s Executive Vice President, Chief Financial Officer (“CFO”) and Treasurer.
Effective as of June 1, 2026, upon Ms. Chew’s retirement, Kevin S. Miller has been named by the Board as Ms. Chew’s successor as Executive Vice President, CFO and Treasurer.
Roy A. Boyd, II , 59, joined the Company as President of STS on May 22, 2026.
In connection with the closing of the Mergers, effective as of the Closing Date, Kathleen Holmgren was appointed to the Board of Directors of the Company (the “ Board ”).
B. John Lindeman, Farha Aslam, Marc L. Brown, Michael DiGregorio, Steven Hollister, Kathleen M. Holmgren, J. Link Leavens, and Adriana Mendizabal tendered their resignations as members of the board of directors of Calavo and from all committees of the board on which they formerly served, effective as of the First Effective Time.
B. John Lindeman, Farha Aslam, Marc L. Brown, Michael DiGregorio, Steven Hollister, Kathleen M. Holmgren, J. Link Leavens, and Adriana Mendizabal tendered their resignations as members of the board of directors of Calavo and from all committees of the board on which they formerly served, effective as of the First Effective Time.
B. John Lindeman, Farha Aslam, Marc L. Brown, Michael DiGregorio, Steven Hollister, Kathleen M. Holmgren, J. Link Leavens, and Adriana Mendizabal tendered their resignations as members of the board of directors of Calavo and from all committees of the board on which they formerly served, effective as of the First Effective Time.
B. John Lindeman, Farha Aslam, Marc L. Brown, Michael DiGregorio, Steven Hollister, Kathleen M. Holmgren, J. Link Leavens, and Adriana Mendizabal tendered their resignations as members of the board of directors of Calavo and from all committees of the board on which they formerly served, effective as of the First Effective Time.
B. John Lindeman, Farha Aslam, Marc L. Brown, Michael DiGregorio, Steven Hollister, Kathleen M. Holmgren, J. Link Leavens, and Adriana Mendizabal tendered their resignations as members of the board of directors of Calavo and from all committees of the board on which they formerly served, effective as of the First Effective Time.
B. John Lindeman, Farha Aslam, Marc L. Brown, Michael DiGregorio, Steven Hollister, Kathleen M. Holmgren, J. Link Leavens, and Adriana Mendizabal tendered their resignations as members of the board of directors of Calavo and from all committees of the board on which they formerly served, effective as of the First Effective Time.
B. John Lindeman, Farha Aslam, Marc L. Brown, Michael DiGregorio, Steven Hollister, Kathleen M. Holmgren, J. Link Leavens, and Adriana Mendizabal tendered their resignations as members of the board of directors of Calavo and from all committees of the board on which they formerly served, effective as of the First Effective Time.
B. John Lindeman, Farha Aslam, Marc L. Brown, Michael DiGregorio, Steven Hollister, Kathleen M. Holmgren, J. Link Leavens, and Adriana Mendizabal tendered their resignations as members of the board of directors of Calavo and from all committees of the board on which they formerly served, effective as of the First Effective Time.
Michael Raabe Effective February 2, 2026, Michael Raabe transitioned from his role as fractional Chief Operating Officer of the Company to a fractional strategic operations and project management support role.
Kelly Marshall On April 15, 2026, Kelly Marshall departed as fractional Chief Marketing Officer of the Company.
C. Derek Campbell Effective January 30, 2026, C. Derek Campbell transitioned from his role as fractional Chief Strategy Officer of the Company to a non-executive advisory capacity.
the effective date of Ms. Jacobson’s resignation as an officer and employee of the Company
On May 24, 2026, the Company’s board of directors (the “Board”) approved Samantha Jacobson’s eligibility to participate in the Company’s non-employee director compensation program (the “Program”).
On May 27, 2026, Eric N. Garcia ceased to be employed as Chief Accounting Officer of Microvast Holdings, Inc. (the “Company”).
On May 21, 2026, the Board appointed Jie (Jay) Sheng, current independent director of the Company, as President, and as Chief Financial Officer, effective June 21, 2026.
On May 21, 2026, Kevin Richardson II notified AIxCrypto Holdings, Inc.'s (the "Company") board of directors (the "Board") of his resignation from the positions of Co-Chief Executive Officer and director of the Company, effective immediately.
Koti Meka resigned from his positions as Chief Financial Officer and director of the Company. Mr. Meka's resignation as director is effective immediately, and his resignation as Chief Financial Officer is effective June 20, 2026.
On May 21, 2026, Campbell Becher resigned from his position as President of the Company, effective immediately.
Koti Meka resigned from his positions as Chief Financial Officer and director of the Company. Mr. Meka's resignation as director is effective immediately, and his resignation as Chief Financial Officer is effective June 20, 2026.
On May 21, 2026, Kevin Richardson II notified AIxCrypto Holdings, Inc.'s (the "Company") board of directors (the "Board") of his resignation from the positions of Co-Chief Executive Officer and director of the Company, effective immediately.
On May 21, 2026, the Board appointed Jerry Wang to serve as a director of the Company, effective immediately.
appointed A. Peyton Bush, IV and R. Chance DeWitt, M.D. to serve as directors of the Company and Red River Bank
appointed A. Peyton Bush, IV and R. Chance DeWitt, M.D. to serve as directors of the Company and Red River Bank
the Board of Directors (the “Board”) of Allogene Therapeutics, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, approved the appointment of Zachary Roberts, M.D., Ph.D. as the Company’s President and Chief Executive Officer, replacing David Chang, M.D., Ph.D. in such capacities.
Dr. Chang will remain on the Board and will become a non-employee director commencing on the Effective Date
Dr. Chang’s last day of service in these positions will be June 30, 2026.
Dr. Roberts currently serves as the Company’s Executive Vice President, Research and Development, and Chief Medical Officer and will continue serving as the Company’s Chief Medical Officer on an interim basis following the Effective Date.
Effective on the Effective Date, Dr. Roberts was also appointed to the Board as a Class I director
Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer.
Effective July 1, 2026, Henry L. Charlton will transition from his role as Chief Commercial and Marketing Officer of Intuitive Surgical, Inc. (the “Company”) and begin serving as Senior Vice President of Global Business Operations of the Company.
On April 15, 2026, Cineverse Corp. (the “Company”) announced that Mark Lindsey would transition out of the Chief Financial Officer role effective as of May 10, 2026.
UGI Corporation (the “Company”) announced today that Kathleen Shea Ballay, the Company’s General Counsel and Chief Legal Officer, intends to resign, effective July 3, 2026.
The board of directors of Blue Ridge Bankshares, Inc. (the “ Company ”) and M. Dean Brown agreed that Mr. Brown will step down as Chief Operations and Technology Officer of the Company and its wholly owned subsidiary Blue Ridge Bank, National Association (the “ Bank ”).
On May 21, 2026, David Enholm notified the Board of Directors (the “Board”) of CleanCore Solutions, Inc. (the “Company”) of his resignation as a member of the Board, effective immediately.
On May 21, 2026, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Tyler Hassen, the Company’s Chief Executive Officer, to fill the vacancy on the Board created by Mr. Enholm’s resignation, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.